Cargando…
Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition
BACKGROUND: Philadelphia chromosome negative myeloproliferative neoplasms (MPNs), including essential thrombocythemia, polycythemia vera, and myelofibrosis, have severe function‐limiting symptom burden that is experienced by the majority of patients. Previous studies have suggested that depression m...
Autores principales: | Padrnos, Leslie, Scherber, Robyn, Geyer, Holly, Langlais, Blake T., Dueck, Amylou C., Kosiorek, Heidi E., Senyak, Zhenya, Clark, Matthew, Boxer, Michael, Cotter, Mary, Harrison, Claire, Stonnington, Cynthia, Geda, Yonas, Mesa, Ruben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666736/ https://www.ncbi.nlm.nih.gov/pubmed/32976697 http://dx.doi.org/10.1002/cam4.3380 |
Ejemplares similares
-
Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
por: Geyer, Holly L., et al.
Publicado: (2015) -
The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms
por: Gowin, Krisstina, et al.
Publicado: (2020) -
Validation of a Modified Version of the Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score
por: Langlais, Blake T., et al.
Publicado: (2021) -
Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care
por: Langlais, Blake T., et al.
Publicado: (2020) -
Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care
por: Christensen, Sarah F., et al.
Publicado: (2021)